This!

In light of new data and a potential increase in colchicine use: 💡Colchicine is a substrate of PGP and CYP3A4. Use with strong inhibitors of PGP and/or CYP3A4 (e.g., clarithromycin, amiodarone) with colchicine can lead to potentially fatal outcomes (i.e., bone marrow toxicity)

Thanks for sharing! Been doing this for a while so it’s nice to have something concrete to send to the insurance companies when they deny the prior authorization #TxID

This is good stuff! Thanks Dr Wooten and Dr Haste for sharing 👏🏽👏🏽👏🏽

Lots of helpful clinical pearls in this chart 👏🏽

More data on the antibody response of SOT patients after COVID 💉 #txpharm what are your thoughts? jamanetwork.com/journals/jama/…

On repeat

We just released an updated joint AST/ASTS/The ISHLT statement on #COVID19 vaccine efficacy in organ transplant recipients. Be sure to view this important information. #TransplantTwitter bit.ly/3xmp34R

All of these! 👏🏽

Looking for talented academic clinical pharmacists to join our Division of Clinical Pharmacy! Please retweet and forward along!

Our #StudentSpotlight today is Stefani Lucarelli from the Class of 2022! Please swipe to read more about her exciting experience during her APPE rotations ☺️ ❤️ #ucsdsspps #pharmacy

Straight genius 💡

True story 🙌🏽

Read this on the package insert and was wondering how this would look when dispensed. Makes sense to create a new dosing pack for patients with moderate renal impairment to minimize wasting pills 🤷🏽‍♀️

We are likely going to go with a tac dose of 0.5-1 mg on day 1, then hold for the entire 5 day course. Hoping for labs 2-3 days after completion or may restart 25-50% until labs can be drawn 😵‍💫🤷🏽‍♀️ Looking forward to hearing from other centers as more experience is had

Feel seen 😆

Twitter keeping me up to date per usual. Thank you, Erin McCreary

Saving this 🔖

My gal pal 👯‍♀️ @ablichvar is 👸 with 7 of 7 abstracts accepted 🙌🏽